Skip to main content

Gendaq Completes Zinc Finger Gene Switch Platform

NEW YORK, March 9 - Gendaq has completed its robotic engineering platform for zinc finger gene switches, which allow researchers to express or knockout individual genes, the company said Friday. 

"We use proprietary selection systems that allow the engineering of high quality zinc finger proteins and we are pleased to announce that we have successfully configured these to a multi-parallel high throughput platform," said Yen Choo, Gendaq's research director in a statement.

Gendaq, based in London, is an offshoot of the Medical Research Council's Laboratory of Molecular Biology, in Cambridge, UK.  The company has been assigned the intellectual property for the lab's zinc finger technology. With 7.5 million pounds ($11 million) in private financing, Gendaq is attempting to commercialize this technology as the Z-switch, a product that allows any gene in a eukaryotic cell to be up- or down-regulated. 

In February, Gendaq published two papers in the Proceedings of the National Academy of Sciences describing the science behind its technology. T he two papers outline new methods of constructing improved zinc finger protein multimers, biomolecules that bind to DNA sequences with high specificity. Gendaq uses these multimers to make Z-switches.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.